Coherus Biosciences's market cap is currently $127.48M. The company's EPS TTM is $-0.1; its P/E ratio is ―; Coherus Biosciences is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 257.24M	$ 211.04M	$ 326.55M	$ 475.82M	$ 356.07M
Gross Profit	$ 94.46M	$ 140.96M	$ 268.96M	$ 438.16M	$ 338.99M
Operating Income	$ -203.20M	$ -256.88M	$ -263.86M	$ 156.32M	$ 107.77M
EBITDA	$ -193.94M	$ -255.58M	$ -260.69M	$ 161.84M	$ 111.03M
Net Income	$ -237.89M	$ -326.63M	$ -306.32M	$ 132.24M	$ 89.83M
Balance Sheet
Cash & Short-Term Investments	$ 117.75M	$ 191.68M	$ 417.19M	$ 541.16M	$ 177.67M
Total Assets	$ 629.60M	$ 480.85M	$ 679.33M	$ 841.65M	$ 408.93M
Total Debt	$ 480.84M	$ 471.06M	$ 408.28M	$ 404.02M	$ 178.39M
Net Debt	$ 377.95M	$ 407.51M	$ -8.91M	$ -137.13M	$ 718.00K
Total Liabilities	$ 823.03M	$ 618.26M	$ 581.61M	$ 560.67M	$ 303.71M
Stockholders' Equity	$ -193.43M	$ -137.42M	$ 97.73M	$ 280.97M	$ 105.21M
Cash Flow
Free Cash Flow	$ -175.17M	$ -243.16M	$ -38.72M	$ 147.09M	$ 15.46M
Operating Cash Flow	$ -174.88M	$ -241.12M	$ -37.43M	$ 154.15M	$ 28.36M
Investing Cash Flow	$ 144.64M	$ -166.85M	$ -138.41M	$ -14.40M	$ -12.73M
Financing Cash Flow	$ 69.60M	$ 54.33M	$ 51.88M	$ 223.95M	$ 89.37M

Currency in USD

Coherus Biosciences Earnings and Revenue History

Income Statement >

Coherus Biosciences Debt to Assets

Balance Sheet >

Coherus Biosciences Cash Flow

Cash Flow >

Coherus Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing